Mechanisms of breast cancer progression and development of novel treatment options

dc.contributor.author	Fernando, Wasundara
dc.date.accessioned	2022-06-20T09:01:55Z
dc.date.available	2022-06-20T09:01:55Z
dc.date.issued	2022-06
dc.identifier.uri	http://ichemcdr.com:8080/xmlui/handle/123456789/160
dc.description	pages 24 & 25	en_US
dc.description.abstract	Breast cancer is the most common cancer among women, with a new breast cancer being diagnosed every 29 seconds. Metastatic triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype that responds poorly to current chemotherapy and immunotherapy. Furthermore, angiogenesis facilitates tumor metastasis by promoting the hematogenic dissemination of cancer cells from solid tumors. TNBCs also have higher levels of cancer stem cells (CSCs). The highly plastic CSCs have enhanced tumor-promoting properties and resistance to therapies leading to metastasis and recurrence.	en_US
dc.language.iso	en	en_US
dc.publisher	Institute of chemistry Ceylon	en_US
dc.relation.ispartofseries	39;1
dc.subject	Mechanisms of breast cancer	en_US
dc.subject	breast cancer	en_US
dc.subject	novel treatment	en_US
dc.title	Mechanisms of breast cancer progression and development of novel treatment options	en_US
dc.type	Article	en_US